Einstein (Sao Paulo, Brazil)HumansBrazilMaleProstatic NeoplasmsAndrogen Antagonists
Judicial demands for prostate cancer treatment in Brazil: androgen receptor pathway inhibitors are an urgent public health problem.
Mariana Avelar da Silveira, Carla de Oliveira Ricomini, Reuli Cordeiro da Silva, Flavio Tocci Moreira, Carlos Henrique Sartorato Pedrotti, Vanessa Damazio Teich, Luciana Holtz de Camargo Barros, Sidney Glina, Fernando Korkes
Published: 202510.31744/einstein_journal/2025GS1301
Abstract
Open AccessA total of 89% of the 3,136 legal demands sought medication. Androgen inhibitors amounted to 78.8% of all lawsuits, particularly abiraterone. There is a growth tendency in judicialization, with a 30-fold increase over 4 years. The estimated annual financial burden of judicialization on the Brazilian United Public Health System has reached BRL 783 million.